The Genetics of Breast Cancer
Breast cancer is not often hereditary, however, inheriting mutated versions of certain genes can greatly increase your risk. If you have a relative, or more than one, with breast cancer then it is possible to have genetic testing done which can indicate if you are at a higher risk for developing breast cancer than the general population.
When is Breast Cancer Hereditary?
Five to ten percent of breast cancers are associated with inherited factors. This means that the vast majority of breast cancer patients do not have a family history. However, if you have a first-degree female relative (such as your mother, sister, or daughter) diagnosed with breast cancer, your risk is doubled. Add a second first-degree relative and it goes up to five times.
Male breast cancer is also affected by hereditary factors, to about the same degree. However, there is also a dramatic increase in risk if you have a first degree relative with breast cancer, whether male or female. The same genes that cause an increased risk in women can also affect men.
What Genes are Associated with Breast Cancer?
The two inherited genes that are most commonly associated with breast cancer are BRCA1 and BRCA2. These genes are dominant, which means you only need one copy of the gene to increase your risk.
For women, without the BRCA1 or BRCA2 mutation, the average risk of developing breast cancer is 12%, but estimates say that 55 to 65% of women with the BRCA1 mutation will develop breast cancer before age 70. The risk for those with BRCA2 is about 45%. Estimates, however, vary, with some studies, such as one by the BRCA1 and BRCA2 Cohort Consortium showing a risk as high as 85% for some populations. The genes are also associated with being diagnosed younger and having cancer in both breasts.
For men, the risk is very low, with an estimated risk of 1.2% for BRCA1 carriers and 6.8% for BRCA2, again by age 70, according to a study by the Institute of Human Genetics at the University of California. However, this compares to a typical risk level of 0.12%, so while the risk is low it is considerably higher than the general population.
These genes also increase the risk of ovarian cancer in women and prostate cancer in men. The BRCA mutations are more common in Ashkenazi (Eastern European) Jews but can show up in any ethnic group.
Additional Genes that Can Increase Breast Cancer Risk
There are fifteen other genes that also increase your risk of developing breast cancer (and potentially other cancers such as ovarian or prostate cancer) if they are mutated, but not as much, some of which are associated with other diseases:
- TP53 - this gene helps stop the growth of cells with damaged DNA and increases your risk of breast cancer as well as leukemia, brain tumors, and sarcomas.
- CHEK2 - a DNA repair gene that affects breast cancer risk.
- CDH1 - affects the risk of a rare type of stomach cancer and also of invasive lobular breast cancer (a cancer of the milk glands which is prone to spreading into the lymph system).
- ATM - another DNA repair gene that has been linked to a high rate of cancer.
- STK11 - mutations of the gene cause a higher risk of many types of cancer, including breast cancer.
- PTEN - this gene regulates cell growth, and mutations increase the risk of breast cancer as well as benign (non-cancerous) growth in the breasts.
- PALB2 - this gene interacts with the BRCA2 gene, resulting in a higher risk especially if you have mutations in both.
- NBN - this is a gene in the MRN complex which has a strong link to breast cancer. Mutations can also cause slow growth and other health problems.
- MRE11A - another gene in the MRN complex, linked to ataxia-telangiectasia disorder.
- RAD50 - the third problem gene in the MRN complex. Mutations here have been linked to a higher risk in some families.
- BARD1 - a gene that works with BRCA1, and a mutation can also increase the risk of breast and possibly ovarian cancer.
- BRIP1 - mutations on this gene are associated with a higher risk of breast and ovarian cancer.
- MSH6 - a mutation on this gene has been linked to many types of cancer, particularly ovarian, but a study in 2018 showed it also doubles your risk of breast cancer.
- PMS2 - mutation here is also linked to many types of cancer, much like MSH6.
- RAD51C - a mutated copy of this gene increases the risk of breast and ovarian cancer.
Should You Get Cancer Genetic Testing?
There are several factors you should consider when deciding whether or not genetic testing for breast cancer is right for you. If you or family members on either side of your family meet one or more of the following criteria, genetic testing may be beneficial for you:
- A breast cancer diagnosis before the age of 50
- Triple-negative breast cancer before the age of 60
- Ovarian cancer at any age
- Male breast cancer at any age
- Three or more relatives with breast cancer, ovarian cancer, pancreatic cancer, or aggressive prostate cancer
- Ashkenazi Jewish heritage with a history of cancer
- Other indicators that might mean genetic testing could be helpful include a history of cancer across multiple generations, developing cancer at a young age, and one person being diagnosed with multiple forms of cancer.
A genetic counselor will be more than happy to talk with you further if you feel like you might be a candidate. They will look at your family history of breast and certain other cancers. A good counselor will help you understand your genetic risk and make the decision whether or not to have the screening test yourself. They will not push you into a decision but will explain the pros and cons of your decision.
What Should You Do if you Do Have a Mutation on one of these Genes?
Discovering that you have a mutation on the BRCA genes does not mean you will get cancer, only that you have a higher risk of developing it. Many people with these genes stay perfectly healthy.
If your genetic test results show a possible abnormal gene, then your doctor may recommend that you start mammograms earlier than the normal age, or that you are screened using a breast ultrasound or MRI.
- Per NCCN guidelines, self-exams should be done regularly, after being taught by a clinician how to do it.
- You should have a clinical breast exam every six to twelve months starting at age 25.
- Your genetic counselor will work with your doctor to make sure that you are on the right screening program. They will also talk to you about your risk and how you may feel about it.
Some women with extremely high risk (such as multiple genetic anomalies) have elected to have a preventive mastectomy or to have their ovaries removed once they are done having children. Because of the risk of surgery, this is something that should be considered carefully. Reconstruction after a double mastectomy can also be difficult and expensive. Women with BRCA mutations who develop cancer in one breast may elect to have both breasts removed because of the much higher risk of a second tumor developing.
If you are a man, you should perform regular breast self-exams and start prostate cancer screening at age 40.
Some people may find psychotherapy helpful if they get a positive result; or even if they get a negative result on a variant common in their family, which can trigger survivors' guilt.
If you had a test done more than five years ago, then you may want to get another test, as new mutations are being developed all the time. Bear in mind that as most breast cancer is not hereditary, a negative result does not mean you are "safe," as only 5 to 10% of breast cancers are caused by inherited mutations.
How Do You Get Started?
If you believe genetic testing for breast cancer is right for you and your family, and you are located in the Portland-Vancouver area, you can easily schedule an appointment with one of Compass Oncology's Genetic Counselors. If you had a test done more than five years ago, then you may want to get another test, as new mutations are being developed all the time. Bear in mind that as most breast cancer is not hereditary, a negative result does not mean you are "safe," as only 5 to 10% of breast cancers are caused by inherited mutations.